|
|
Valeant Pharmaceuticals International - Company Profile Snapshot
| Company Profile: |
Valeant Pharmaceuticals International |
| Ticker: |
VRX |
| Exchanges: |
NYSE MSE |
| 2007 Sales: |
872,220,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
3001 |
Business Description
Valeant Pharmaceuticals International. The Group's principal activity is to develop, manufacture and market prescription and non-prescription pharmaceutical products principally in the areas of neurology and dermatology. The Company's growth strategy is to acquire, develop and commercialize new products through strategic partnerships, and build on the company's market in neurology and dermatology. The Group's markets focus primarily in the United States, Canada, Mexico, Brazil and Australia. Headquartered in Orange County, California, Valeant has approximately 2,600 employees worldwide.
|
Not the Report you are looking for? Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
